NEW YORK (AP) _ Cellular Biomedicine Group Inc. (CBMG) on Wednesday reported a loss of $11.5 million in its first quarter.
The New York-based company said it had a loss of 60 cents per share. Losses, adjusted for asset impairment costs, were 59 cents per share.
Cellular Biomedicine shares have declined 14% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $14.02, a drop of 17% in the last 12 months.